CONJUGUÉ D'UN POLYMÈRE, D'UN AGENT ANTI-ANGIOGENÈSE ET D'UNE FRACTION DE CIBLAGE ET UTILISATIONS DE CE CONJUGUÉ POUR TRAITER DES MALADIES ANGIOGÉNIQUES OSSEUSES
Conjugates of hydroxypropyl methacrylamide (HPMA)-derived copolymers having attached thereto TNP-470 and a high load (e.g., higher than 3 mol %) of alendronate (ALN), and processes of preparing same are disclosed. Conjugates of polymers or copolymers having attached thereto an anti-angiogenesis agent and an oligoaspartate bone targeting agent, and processes of preparing same, are further disclosed. Pharmaceutical compositions containing these conjugates and uses thereof in the treatment and monitoring of bone related disorders are also disclosed.